| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/21/2007 | US20070141064 Fully human hybridoma fusion partner cell lines |
| 06/21/2007 | US20070141063 Peptide having ability to activate cancer-related gene |
| 06/21/2007 | US20070141061 Protein involved in carcinoma |
| 06/21/2007 | US20070141060 Hmgb1 protein inhibitors for the regulation of smooth muscle cells and endothelial cells profileration |
| 06/21/2007 | US20070141058 Method of correcting immunopathological reactions and a medicament |
| 06/21/2007 | US20070141057 Anti-TNF antibodies and peptides of human tumor necrosis factor |
| 06/21/2007 | US20070141056 Growth factor homolog zvegf3 |
| 06/21/2007 | US20070141055 Methods and compositions for protein-hydroxy apatite complexes and their application in testing and modulating immunological system including a novel in vitro test for the detection of antibodies against calcium binding protein-hydroxy apatite complexes |
| 06/21/2007 | US20070141052 Fc region variants |
| 06/21/2007 | US20070141051 Nucleic acid encoding cytokine receptor zcytor17 |
| 06/21/2007 | US20070141049 Bivalent IgY antibody constructs for diagnostic and therapeutic applications |
| 06/21/2007 | US20070141048 Using multiplex overlap-extension reverse transcriptase polymerase chain reaction to combine two or more nucleotide sequences encoding domains or subunits of heteromeric protein in a single reaction |
| 06/21/2007 | US20070141047 Feline immunoglobulin e proteins and compositions thereof |
| 06/21/2007 | US20070141025 Compositions and methods for cancer immunotherapy |
| 06/21/2007 | US20070141024 Mammalian cytokine; reagents and methods |
| 06/21/2007 | US20070140970 Cell targeting conjugates |
| 06/21/2007 | US20070140966 Multivalent immunoglobulin-based bioactive assemblies |
| 06/21/2007 | CA2633956A1 Binding proteins specific for insulin-like growth factors and uses thereof |
| 06/21/2007 | CA2633601A1 Methods for obtaining immortalized antibody secreting cells |
| 06/21/2007 | CA2633594A1 Means and methods for the treatment of tumorous diseases |
| 06/21/2007 | CA2633501A1 Immunoglobulins directed against nogo |
| 06/21/2007 | CA2633468A1 Novel neurotrophic factor protein and uses thereof |
| 06/21/2007 | CA2633399A1 Therapeutic vaccine |
| 06/21/2007 | CA2633038A1 Anti-mn antibodies and methods of using same |
| 06/21/2007 | CA2632983A1 Biological materials and uses thereof |
| 06/21/2007 | CA2632822A1 A beta 1-42 specific monoclonal antibodies with therapeutic properties |
| 06/21/2007 | CA2631938A1 Anti-il-17 antibodies |
| 06/21/2007 | CA2631675A1 Identification of genetic polymorphic variants associated with somatosensory disorders and methods of using the same |
| 06/21/2007 | CA2628388A1 Targeting and tracing of antigens in living cells |
| 06/21/2007 | CA2604928A1 Methods for obtaining optically active epoxides and diols from 2,3-disubstituted and 2,3-trisubstituted epoxides |
| 06/20/2007 | EP1798288A2 Human Toll-like receptor proteins, related reagents and methods |
| 06/20/2007 | EP1798287A2 Mammalian cell membrane proteins and related reagents |
| 06/20/2007 | EP1798286A2 Mammalian cell membrane proteins and related reagents |
| 06/20/2007 | EP1798243A2 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumors |
| 06/20/2007 | EP1798242A2 New anti-GF-IR antibodies and their applications |
| 06/20/2007 | EP1798241A1 Method of manufacturing a hapten between doxycycline and bovine serum albumin and application for detecting doxycycline in humans or animals |
| 06/20/2007 | EP1798240A1 Recombinant triplex scaffold-based polypeptides |
| 06/20/2007 | EP1798239A2 G-protein coupled receptors and uses therefor |
| 06/20/2007 | EP1797897A1 Medicinal composition containing meltrin antagonist |
| 06/20/2007 | EP1797893A2 New composition |
| 06/20/2007 | EP1797432A2 Treating renal cell carcinoma with an anti-tnf human antibody or fragment |
| 06/20/2007 | EP1797200A2 Early detection of hemangiosarcoma and angiosarcoma |
| 06/20/2007 | EP1797127A2 Modified fc molecules |
| 06/20/2007 | EP1797126A1 Compositions monovalent for cd40l binding and methods of use |
| 06/20/2007 | EP1797125A2 Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes |
| 06/20/2007 | EP1797123A1 COMPLEMENTARY PEPTIDES FOR ß-AMYLOID 29-42 PEPTIDE |
| 06/20/2007 | EP1797113A1 Optimized vaccines to provide protection against ebola and other viruses |
| 06/20/2007 | EP1796735A2 Immunotherapy of autoimmune disorders |
| 06/20/2007 | EP1796721A1 Cancerous disease modifying antibodies |
| 06/20/2007 | EP1796711A2 Herstatin or intron 8-encoded domain thereof for modulating signaling mediated by igf-1 receptor and erbb receptors |
| 06/20/2007 | EP1598670B1 METHOD OF IMMUNOASSAYING TARTRATE RESISTANT ACID PHOSPHATASE 5b AND KIT TO BE USED THEREIN |
| 06/20/2007 | EP1485410B1 Diagnostic and therapeutic use of human maguin proteins and nucleic acids for neurodegenerative diseases |
| 06/20/2007 | EP1436331B1 Process for the production of egg yolk antibodies against organochlorine pesticides |
| 06/20/2007 | EP1358353B1 Identification of genetic determinants of polymorphic cyp3a5 expression |
| 06/20/2007 | EP1274840B1 Ligand for herpes simplex virus entry mediator and methods of use |
| 06/20/2007 | EP1179010B1 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 06/20/2007 | CN1985169A Use of TWEAK modulators and inhibitors for the treatment of neurological conditions |
| 06/20/2007 | CN1985002A GM3 synthase as a therapeutic target in microvascular complications of diabetes |
| 06/20/2007 | CN1984999A Tolerance-induced targeted antibody production |
| 06/20/2007 | CN1984993A Plant production of immunoglobulins with reduced fucosylation |
| 06/20/2007 | CN1984931A Anti-CD3 antibodies and methods of use thereof |
| 06/20/2007 | CN1984930A Leptin antagonist and method for quantitative measurement of leptin |
| 06/20/2007 | CN1984929A Methods for reducing biofilm formation in infectious bacteria |
| 06/20/2007 | CN1984925A Genes and polypeptides relating to prostate cancers |
| 06/20/2007 | CN1984680A Antibodies |
| 06/20/2007 | CN1984672A Modulation of NKG2D |
| 06/20/2007 | CN1982459A Method of preparing mammal cell kinetin synthesis inhibitoroy factor |
| 06/20/2007 | CN1982455A Polynucleotide for inhibiting Wnt activity, its encoded polypeptide and use |
| 06/20/2007 | CN1982454A Related gene of osteoporosis, its encoded protein and use |
| 06/20/2007 | CN1982453A Use of human gene and its encoded polypeptide |
| 06/20/2007 | CN1982338A Neutralized monoclone antibody 4C13 of antiricin, its production and use |
| 06/20/2007 | CN1982337A Synthesis of polypeptide antibody from anti-human myocardial troponin I, its production and use |
| 06/20/2007 | CN1982324A Oncogene, recombinant protein derived therefrom, and uses thereof |
| 06/20/2007 | CN1981868A Combined use of anti-cytokine antibodies or antagonists and anti-CD20 for treatment of B cell lymphoma |
| 06/20/2007 | CN1322127C BASB029 polynucleotide(s) and polypeptides from i(neisseria meningitidis) |
| 06/20/2007 | CN1322118C Mononal antibody against avermectin, hybridoma cell line secreting the same and its preparation method |
| 06/20/2007 | CN1322010C Method for preparing polyclonal antibody of ascites from anti aflatoxin B1 of rat |
| 06/20/2007 | CN1322009C Monoclonal antibody of virus receptor of anti leukoplakia disease and preparation method |
| 06/20/2007 | CN1322008C Monoclonal antibody of anti lymphocyst virus of and preparation method |
| 06/20/2007 | CN1322005C Constructs of branched synthetic peptide immunogens with artificial T helper cell epitopes coupled to B cell epitopes |
| 06/20/2007 | CN1321695C Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases |
| 06/19/2007 | US7232898 Chimeric IgE polypeptides and host cells |
| 06/19/2007 | US7232892 Antibodies to a polypeptide encoded by a nucleic acid differentailly expressed in stomach, lung and melanoma tumor |
| 06/19/2007 | US7232891 Detection of tumor cells in sample; obtain cells, incubate with antibody, detect formation of leuteinizing hormone complex, presence of complex indicates presence of tumor cells |
| 06/19/2007 | US7232890 Diagnosis, therapy of breast cancer; adjustment of gene expression |
| 06/19/2007 | US7232889 PRO300 antibodies |
| 06/19/2007 | US7232888 Antibodies against tumor surface antigens |
| 06/19/2007 | US7232887 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 06/19/2007 | US7232672 P450 enzymes, nucleic acids encoding them and methods of making and using them |
| 06/19/2007 | US7232661 Diagnostic agents for the prenatal diagnosis of preterm delivery, fetal infection, and fetal damage, and diagnostic kit containing the same |
| 06/19/2007 | US7232660 Bioassay for detection of membrane protein receptor ligand associated with modulation of hodgkin's disease; carrier for delivering diagnostic and cytotoxic agents to tumors; gene therapy |
| 06/19/2007 | US7232570 ERAAP modulators regulate immune responses |
| 06/19/2007 | US7232568 Compositions and methods for treating hyperimmune response in the eye |
| 06/19/2007 | US7232567 Anti-CCR1 antibodies and methods of use thereof |
| 06/19/2007 | US7232566 Methods for treating HIV infected subjects |
| 06/19/2007 | CA2444794C Technique for extracorporeal treatment of blood |
| 06/19/2007 | CA2159112C Anti-microbial agents and screening method therefor |
| 06/19/2007 | CA2073124C Tumor antigen specific antibody |
| 06/19/2007 | CA2066738C Prevention, treatment and amelioration of a pathology characterized by brain inflammation |
| 06/16/2007 | CA2557055A1 Peptides for stimulating an immune response against melanoma |